Functional recovery of human mesenteric and coronary arteries after cryopreservation at −196° C in a serum-free medium  by Müller-Schweinitzer, E. et al.
Functional recovery of  human mesenteric 
and coronary arteries after 
cryopreservation at -196  ° C in a 
serum-free medium 
E. M i i l l e r -Schwein i t zer ,  MD,  M.  J. M ihatsch ,  MD,  M.  Schi l l ing,  MD,  and 
W.  E. Haefe l i ,  MD,  Basel and Bern, Switzerland 
Purpose: Long-term patency of  cryopreserved vascular grafts is determined by maintained 
cellular and tissue viability, which implies preservation of  various biochemical, smooth 
muscle, and endothelial functions. Therefore, it was investigated whether the presence of  
fetal calf serum (FCS) in the cryomedium improves the postthaw contractile and endo- 
thelial function of  human arteries. 
Methods: Rings from human mesenteric (HMA) and left circumflex coronary arteries 
(HCA) obtained from organ donors were randomized into three groups and studied 
either unfrozen or after storage for 3 to 6 weeks at -196°C while suspended in 
Krebs-Henseleit solution without or with 20% FCS as the vehicles and 1.8 mol /L  
dimethyl sulfoxide and 0.1 mol /L  sucrose as cryoprotecting agents. The samples were 
slowly frozen to -70  ° C and then stored in l iquid nitrogen. Before use, the tissues were 
thawed within 3 minutes in a 40 ° C water bath. 
Results: After thawing the sensitivity to various agonists and maximal responses to the 
endothel ium-independent r laxing agent sodium nitroprusside were unchanged. How- 
ever, after cryopreservation f  HMA was performed without and with FCS, maximal 
contractile responses to noradrenaline were significantly reduced to 10.1 -+ 0.7 gm and 
9.9 -+ 0.9 gm compared with 13.3 -+ 0.6 gm in unfrozen HMA (mean _+ SEM, n = 15). 
After cryopreservation f  HCA was performed without and with FCS, maximal contrac- 
tile responses to prostaglandin Fz~ (6.9 - 0.4 gm in unfrozen HCA)  were significantly 
reduced to 4.3 -+ 0.3 gm and 3.8 -+ 0.2 gm (mean -+ SEM, n = 6). In both types of  
arteries cryopreservation also attenuated significantly the endothel ium-dependent relax- 
ant responses to bradykinin during U46619 (10 nmol /L) - induced tone. In HMA the 
maximal bradykinin-induced relaxation (85% -+ 4%) was significantly diminished to 29% 
-+ 7% and 38% +- 9% after cryopreservation without and with FCS (mean -+ SEM, n = 6). 
In HCA maximal bradykinin-induced relaxation (88% -+ 4%) was significantly diminished 
to 26% -+ 10% and 36% -+ 11% after cryopreservation without and with FCS (mean -+ 
SEM, n = 6). This result was reflected by a marked endothelial denudation in all groups 
of  cryopreserved arteries. Neither functional nor morphologic preservation of  the endo- 
thdial  cell l ining was significantly improved by FCS supplementation f  the cryomedium. 
Conclusions: Cryopreservation diminished contractile and endothel ium-dependent relax- 
ant responses of  human arteries. The presence of  FCS in the cryomedium did not modify 
these changes. (J Vasc Surg 1997;25:743-50.) 
Cryopreserved human b lood vessels are being 
used in patients requir ing peripheral or coronary 
bypass grafting 1-4 and for various pharmacologic in- 
vestigations in drug development,  s,6 Ideally for both 
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purposes preservation o f  all vascular cell types should 
be guaranteed. A l though dur ing the last few years 
the technique o f  cryopreservation f isolated tissues 
in l iquid nitrogen (at -196  ° C) has been improved 
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and shown to be effective in preserving various bio- 
chemical and smooth muscle cell functions, signifi- 
cant preservation ofthe endothelial cell lining during 
the freezing/thawing procedure is still unsatisfac- 
tory. Today two types of blood vessels, the saphe- 
nous vein and the internal mammary artery, are the 
most commonly used autogenous grafts in recon- 
structive peripheral vascular and coronary bypass ur- 
gery. However, the patency rates of coronary bypass 
vein grafts may be limited by complications such as 
vasospasms, 7-~° and the evidence suggests that espe- 
ciaily in coronary revascularization maintained endo- 
thelial function is one of the most important deter- 
minants of patency rates of the graft material. H 13 
Arteries generally exhibit not only different response 
profiles to endogenous vasoactive substances but also 
a more pronounced production of endothelium-de- 
rived relaxing factor(s) than do veins. 12-16 Therefore, 
cryopreserved arteries might be potential alternatives 
when autogenous conduits are not available. Com- 
parative studies on canine coronary arteries revealed 
significant improvement of the postthaw endotheli- 
urn-dependent relaxant responses when a serum-sup- 
plemented cryomedium was used. 17 In contrast, no 
improvement of the postthaw endothelial function 
could be demonstrated with porcine coronary arter- 
ies after cryostorage in a cryomedium containing 
20% fetal calf serum (FCS), s,6 indicating the exis- 
tence of considerable species differences. 
The purpose of this study was therefore to inves- 
tigate whether a serum-supplemented cryomedium 
could improve the preservation ofarterial endothelial 
cell lining along with its function in arteries of hu- 
man origin. 
MATERIAL  AND METHODS 
Tissue preparation. Samples of human mesen- 
teric and circumflex coronary arteries were taken 
from five organ donors (three male, two female; 18 
to 65 years old; mean age, 37.4 +- 8.5 years) after 
permission was obtained from the local ethical com- 
mittee. The tissues were placed in Krebs-Henseleit 
(KH) solution (composition mmol/L:  NaC1 118, 
KC1 4.7, MgSO4 1.2, CaCI 2 1.2, Kt-I2PO 4 1.2, 
NaHCO 3 25, glucose 11, ethylenediamine tetraace- 
tic acid 0.03) at room temperature, pH 7.4, and 
transported to the laboratory. Within 12 hours after 
explantation coronary and mesenteric arteries (outer 
diameter ~0.8 to 1 mm) were removed, cleaned of 
surrounding tissue, cut into rings (approximately 2 
mm long), and randomized into three groups for 
investigations in vitro. The samples of "unfrozen 
arteries," group 1, were used immediately or after 
storage overnight at 4 ° C for organ bath studies. The 
arteries of the other two groups were frozen as de- 
scribed in the following text. 
Cryopreservation. For cryopreservation the tis- 
sues were placed in 2 ml liquid nitrogen storage 
ampoules (Gibco AG, Basel, Switzerland) containing 
KH solution at room temperature either without 
(group 2) or with 20% FCS (group 3) as the vehicles 
and 1.8 mol /L  dimethyl sulfoxide (Me2SO) and 0.1 
mol /L  sucrose as the cryoprotecting a ents. Within 
10 minutes afterwards the ampoules were placed in a 
polystyrene box (11 × 11 × 22 cm) and were slowly 
frozen at a mean cooling rate of approximately 
1.3 ° C/rain in a freezer maintained at -70  ° C. After 
2 to 3 hours the ampoules were transferred into 
liquid nitrogen ( -196 ° C), where they were stored 
for 3 to 6 weeks until use. Before use the tissues were 
thawed rapidly within 3 minutes by placing the am- 
poules in a 40 ° C water bath. Thereafter the prepara- 
tions were rinsed in a dish containing KH solution at 
room temperature and suspended in 10 ml organ 
baths for isometric tension recording. 
Organ bath studies. The arterial tings were 
mounted between two hooks of stainless teel wire 
(diameter, 0.15 mm), suspended in 10 ml organ 
baths containing KH solution at 37 ° C, pH 7.4, and 
gassed continuously with 5% CO 2 in oxygen. The 
tension of the rings was recorded isometrically under 
a resting tension of 1 gm with electromechanical 
transducers (Statham model UC 3) and a potentio- 
metric recorder. At the beginning of the experiments 
the rings were stretched to an initial tension of 2 gm 
and allowed to relax and equilibrate for approxi- 
mately 3 hours in the bathing medium, which was 
changed every 15 minutes. During this time the 
mesenteric and coronary arteries were challenged 
once with a submaximal concentration of noradren- 
aline (1 ~mol/L)  or prostaglandin F2, x (PGF2~, 1 
~mol/L)  respectively, and the preload of the rings 
was repeatedly readjusted until a stable baseline ten- 
sion of i gm was achieved. Concentration-response 
curves for agonists were determined by cumulative 
additions, the concentration being increased when 
the maximum effect had been produced by the previ- 
ous concentration. In some experiments indometha- 
cin (1 ~zmol/L) was added 20 minutes before the 
first administration of the agonist o block endoge- 
nous prostaglandin synthesis. When relaxant re- 
sponses were investigated, active tone was induced 
by addition of 10 ~mol /L  of the thromboxane ana- 
log U46619 (9,11-dideoxy-1 i s ,  9~-epoxymethano- 
PGF2~), a concentration producing approximately 
50% of maximal response. After these concentration- 
response curves were completed, sodium nitroprus- 
side (SNP, 100 Ixmol/L) was added to induce com- 
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Table I. Parameters calculated for the contractile and relaxant responses of human mesenteric 
arteries in vitro 
Frozen in KH Frozen in KH 
n Fresh artery, solution + 20% FCS 
Potency (pD 2 values) 
Noradrenaline 15 6.06 -+ 0.03 6.31 ± 0.06 6,20 ± 0.09 
PGF2~, 6 5.78 ± 0.13 5.82 ± 0.07 5.66 ± 0.07 
PGFz~-Indomethacin 6 6.27 ± 0.13 6.12 ± 0.11 5.98 ± 0.12 
Sodium nitroprusside 7 6.72 ± 0.11 6.97 ± 0.22 7,07 ± 0.16 
Bradykinin 6 8.72 ± 0.18 7.95 ± 0.26* 7,88 ± 0.28* 
Substance P 6 9.12 ± 0.11 9.09 ± 0.25 8,99 ± 0.22 
Efficacy (Emax) 
Noradrenaline (gm) 15 13.3 ± 0.6 10.1 ± 0.7* 9.9 -+ 0.9* 
PGF2~ (gm) 6 8.8 ± 1.6 8.7 ± 1.6 8.1 +- 0.7 
PGF2~-Indomethacin (gm) 6 11.8 ± 1.7 6.7 ± 1.4" 8.6 ± 0.5 
U46619, 10 nmol/L (gm) 19 3.7 -+ 0.6 5.1 ± 0.8 3.9 ± 0.8 
Sodium nitroprusside (%) 7 -50 ± 3 -65 ± 9 -62 ± 7 
Bradykinin (% SNP) 6 -85 ± 4 -29 ± 7* -38 ± 9* 
Substance P (% SNP) 6 -70 ± 4 -15 ± 4* -16 ± 4* 
Data are presented as mean _+ SEM. 
*Significant difference against values in fresh arteries. 
plete relaxation of the arterial rings. This effect was 
taken as 100% relaxation. On each arterial ring only 
one contracting agonist was tested followed by inves- 
tigation of one relaxant compound. 
Histologic examinations. After each functional 
study was completed, the rings were carefully 
removed from the hooks, fixed in 10% formalin, 
dehydrated, and embedded in paraffin. Each arterial 
sample was divided into two segments, and cross- 
sections were investigated. Five micrometer-thick 
paraffin sections were cut and stained with hematox- 
ylin-eosin (HE) for semiquantitative assessment by 
light microscopy. On the basis of  endothelial cells 
lining the inner surface of the examined arterial rings, 
the degree of  endothelial denudation was graded on 
a scale of  0 (endothelial cells completely acking) to 4 
(endothelial cell lining completely preserved). 
Drugs. The following pharmacologic agents 
were used: bradykinin triacetate, indomethacin, or- 
adrenaline hydrochloride, U46619 (9,11-dideoxy- 
11eg9c~-epoxymethano-PGFz~), sodium nitroprus- 
side (Sigma, Munich, Germany), Substance P acetate 
(Bachem, Bubendorf, Switzerland), and PGF2~ (Di- 
nolytic, Provet, Lyssach, Switzerland). A stock solu- 
tion (10 retool/L) of indomethacin was prepared 
with 0.1 mol /L  NaOH solution. U46619 was dis- 
solved in ethanol and diluted to give a 1 mmol /L  
solution containing 60% ethanol. Further dilutions 
were performed in 5% glucose or normal saline solu- 
tion. Samples of U46619 (1 ixmol/L) and indo- 
methacin (0.1 mmol /L)  were stored at -20  ° C until 
use. All other compounds were dissolved in saline 
solution just before use. 
Data analysis. Concentration-response curves 
were analyzed with a computer program in RS/1 
(BBN Software Products Corporation, Cambridge, 
Mass.), and Ema x (maximal effects) and pD 2 values 
(negative logarithm of the molar agonist concen- 
tration producing 50% of Emax) were derived from 
this analysis. One-way analysis of  variance 
(ANOVA) was performed, followed by the Bonfer- 
roni-corrected t test to assign differences to indi- 
vidual between-group comparisons when overall 
significance (p < 0.05) was attained. Data are 
presented as mean __+ SEM. In each series of exper- 
iments arteries from two organ donors were used. 
The n values in the Figure legends and Tables refer 
to the number of  arterial rings used. 
RESULTS 
Functional investigations 
Mesenteric arteries. After thawing contractile 
responses to noradrenaline of cryopreserved human 
mesenteric arteries occurred within the same concen- 
tration ranges as in unfrozen tissues; however, in 
both groups of cryopreserved arteries maximal con- 
tractile responses to the amine proved to be signifi- 
cantly diminished by 25% (Table I, Fig. 1). In con- 
trast, contractile responses to l0 nmol /L  U46619 (a 
concentration producing approximately 50% of max- 
imal effect) appeared unchanged when tested after 
cq,opreservation (Table I). The same was true for 
PGF2,. After cryopreservation pD2 values and maxi- 
mal responses to PGF2~ appeared to be similar to 
those obtained with unfrozen control tissues (Table 
I, Fig. 2, top). However, after blockade of prosta- 
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Fig. 1. Cumulative concentration-response curves to 
noradrenaline on rings from human mesenteric arteries 
unfrozen (solid circles) and after cryopreservation in KH 
solution without (empty circles) and with 20% fetal calf 
serum (solid squares). Points represent means from 15 
individual experiments; bars represent mean values _+ 
SEM. 
glandin synthetase by 1 Ixmol/L indomethacin was 
performed, the postthaw maximal responses to 
PGF2~ were reduced by 43% and 27% in mesenteric 
arteries, which had been frozen without and with 
FCS, respectively (Table I, Fig. 2, bottom). 
Sodium nitroprusside was used to investigate en- 
dothelium-independent r laxant responses of arterial 
rings during active tone induced by the addition of 
10 nmol/L U46619. In this series of experiments 
the effects were expressed as percentages of the active 
tone induced by U46619 in addition to the existing 
passive preload. After cryopreservation the relaxant 
effects of sodium nitroprusside appeared to be rather 
enhanced compared with the effects obtained with 
unfrozen control preparations; the differences were, 
however, not significant (Table I, Fig. 3, top). To 
investigate endothelium-dependent relaxant re- 
sponses, bradykinin and substance P were used. 
Compared with unfrozen control tings the relaxant 
effects of both compounds were markedly dimin- 
ished when investigated after thawing of cryostored 
arteries (Table I). Taking the effects on unfrozen 
control tissues as 100%, bradykinin relaxed precon- 
tracted rings of mesenteric arteries that had been 
frozen in media without and with FCS by 34% _+ 8% 
and 45% _+ 11%, respectively (Fig. 3, middle). The 
same was true for the effects of substance P, which 
relaxed the arterial rings by 21% + 6% and 23% -+ 6% 
after cryostorage without and with FCS, respectively 
(Fig. 3, bottom). 
g 
12- 
10' 
8' 
6- 
-7 -is 
PGF2~ (log M) 
o} 
v 
t -  
O 
tar} ¢.-  
I-- 
12- 
10- 
8- 
6- 
4- 
2- 
0 
...... | ...... i 
-7 -6 -5 -4 
PGF2~ (log M) 
Fig. 2. Cumulative concentration-response curves on 
rings from human mesenteric arteries unfrozen (solid cir- 
cles) and after cryopreservation in KH solution without 
(empty circles) and with 20% fetal calf serum (solid squares) 
for PGF2~ without (top) and in presence of 1 ixmol/L 
indomethacin (bottom). Effects are expressed in grams; 
points represent mean values from six individual experi- 
ments. Bars represent mean values + SEM. 
Coronary arteries. As observed with mesenteric 
arteries, the postthaw contractile responses of coro- 
nary arteries to U46619 (10 nmol/L) were un- 
changed (Table II). On the other hand, after thaw- 
ing maximal responses to PGF2~ proved to be 
significantly diminished by 38% + 4% and 45% + 3% 
in rings cryopreserved without and with FCS, respec- 
tively, although there was no significant change in 
the pD 2 values (Table II, Fig. 4, top). Endothelium- 
independent relaxant responses to sodium nitroprus- 
side occurred with unchanged maxima, but 4 and 5 
times higher concentrations of the compound were 
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required to produce the 50% effect (Table II, Fig. 4, 
middle). In contrast, endothelium-dependent r lax- 
ant responses to bradykinin were markedly diminished 
by 70% _+ 11% and 59% + 13% in coronary arteries that 
had been frozen without and with FCS, and again 
significantly higher concentrations of bradykinin were 
required to elicit these effects (Table II, Fig. 4, bottom). 
Morphologic examinations 
A total of 30 mesenteric and 16 coronary ring 
segments underwent histologic examination after the 
in vitro experiments were terminated. Generally, 
cryopreservation f the arterial segments did not 
change the morphologic appearance of the medial 
layer in these tissues. However, there were consider- 
able differences in the preservation of the endothelial 
lining. Semiquantitative assessment of the endothe- 
lium revealed marked endothelial denudation in 
rings from both mesenteric and coronary arteries that 
had been frozen without and with serum supplemen- 
tation compared with unfrozen preparations. The 
endothelium of frozen/thawed coronary arteries ap- 
peared to be somewhat better preserved than that of 
mesenteric arteries; however, after cryopreservation 
generally at least 50% of the endothelium was de- 
tached or removed (Table III), and there was no 
improvement if arteries had been cryopreserved in a 
serum-supplemented medium. 
D ISCUSSION 
The aim of this study was to investigate whether 
cryopreservation f  human arteries in a serum-sup- 
plemented medium improves the postthaw func- 
tional recovery of smooth muscle and endothelial 
cells. The effectiveness of two cryomedia, KH solu- 
tion without and with 20% FCS, was compared. Both 
media contained imethylsulfoxide and sucrose, the 
combined action of  which has been shown to give 
optimal protection against cryoinjury in various ani- 
mal blood vessels. 18 Furthermore, based on the ob- 
servation that prolonged exposure of canine femoral 
arteries to a dimethyl sulfoxide-containing medium 
may result in progressive reduction of the postthaw 
functional recovery) 9 a relatively short incubation 
time of  only 10 minutes at room temperature was 
allowed to equilibrate the tissues with the cryomedia 
before the cooling process was started. With both 
media the postthaw maximal responses of human 
mesenteric arteries to noradrenaline, which are medi- 
ated predominantly by ~xl-adrenoceptors, 2° proved 
to be reduced compared with responses obtained 
with unfrozen control tissues, but there was no sig- 
nificant difference between the contractile force de- 
f -  
0 
:8 -20- 
'- -40- 
O 
O 
-100 = 
0 
-9 -B -Y -is 
Sodium nitroprusside (log M) 
0 
n -20, 
Z 
09 
>~ -40 
E -60, 
o 
--801 
-101 
-I'o -i3 -7 -is 
Bradykinin (log M) 
0 
~: -20, 
-40. 
E -60. 
-80, 
-100 
-b -i3 -i3 
Substance P (log M) 
Fig. 3. Cumulative concentration-response curves on 
rings from human mesenteric arteries, unfrozen (solid cir- 
cles) and after cryopreservation in KH solution without 
(emp~ circles) and with 20% fetal calf serum (solid squares) 
during active tone induced by U46619 (10 nmol/L) for 
sodium nitroprusside (top, for each point n = 7), for 
bradykinin (middle, for each point n -- 6), and for sub- 
stance P (bottom, for each point n - 6), expressed as 
percentage ofmaximal relaxation induced by 100 ~mol/L 
sodium nitroprusside (SNP). Bars represent mean values + 
SEM. 
veloped by tings that had been cryopreserved with- 
out or with serum-supplementation of the medium. 
It has been demonstrated that relaxant prosta- 
glandins modulate both basal tone and receptor- 
mediated contractile responses of  human mesenteric 
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Table I I .  Parameters calculated for the contractile and relaxant responses of  human circumflex 
coronary arteries in vitro 
Frozen in KH Frozen in KH 
n Fresh arte~ solution + 20% FCS 
Potency (pD 2 values) 
PGF2~ 6 6.02 -+ 0.07 5.79 -+ 0.03 5.90 -+ 0.03 
Sodium nitroprusside 9 7.38 -+ 0.09 6.76 -+ 0.09* 6.71 -+ 0.11" 
Bradykinin 6 9.21 _+ 0.18 7.66 _+ 0.22* 7.74 _+ 0.43* 
Efficacy (Emax) 
PGF2~ (gm) 6 6.9 + 0.4 4.3 -4- 0.3* 3.8 + 0.2* 
U46619, 10 nmol /L  (gm) 15 2.2 _+ 0.3 2.4 -+ 0.3 2.3 + 0.3 
Sodium nitroprusside (%) 9 -60  + 2 -64  + 6 -62  + 7 
Bradykinin (% SNP) 6 -88  + 4 -26  -+ 10" -36  + 11" 
Data are presented as means _+ SEM. 
*Significant difference against values in fresh arteries. 
Table I I I .  Preservation of endothelial cells in rings from human mesenteric and circumflex coronary 
arteries as assessed after the in vitro experiments by light microscopy 
Score 4 3 2 I 0 Total 
Mesenteric artery 
Fresh artery 2 3 1 6 
Frozen in KH solution 6 4 2 12 
Frozen in KH + 20% FCS 2 5 5 12 
Coronary artery 
Fresh artery 5 1 6 
Frozen in KH solution 1 3 1 5* 
Frozen in KH + 20% FCS 2 1 2 5* 
Score: 4 ~ endothelial cell ining preserved, 1 = single cells present, 0 = endothelium not seen. * = 1 preparation in this group could not 
be assessed. 
arteries in vitro. 2~ Furthermore, biochemical experi- 
ments on human saphenous veins have shown that 
70% of vortex-stimulated prostacyclin production as 
assessed by measurement of the 6-keto-prostaglan- 
din F2~ release derives from the endothelium 22and 
that this endothelial function is completely preserved 
after slow freezing in the presence ofdimethyl sulfox- 
idc. 23 In our present functional studies blockade of 
the endogenous prostaglandin synthesis by indo- 
methacin enhanced responses to PGF2~ of  mesen- 
teric arteries before but not after cryopreservation. 
These findings supported the contention that in hu- 
man mesenteric arteries under normal conditions 
contractile responses to PGF2~ are counteracted by 
endogenous relaxing prostanoids 21 and suggested 
that the impairment of this mechanism in f rozen/  
thawed arteries was due to cryoinjury of the endothe- 
lial cells. The same might be true for human coronary 
arteries, the basal tone of which is modulated by 
endogenous dilator products of arachidonic acid as 
well. 24 Because in this study coronary arteries were 
investigated without cyclooxygenase inhibition by 
indomethacin, the postthaw contractile responses of 
these vessels to PGF2~ might have been rather over- 
estimated. In similar experiments with human coro- 
nary arteries and a serum-supplemented cryome- 
dium, Ku et al. 2s,26 obtained postthaw contractile 
responses of only approximately 20%, whereas in our 
study these effects amounted to 55% of  that obtained 
with unfrozen control tissues. The main reason for 
this apparent discrepancy may derive from the block- 
ade of endogenous dilator products of  the cyclooxy- 
genase pathway by indomcthacin in those experi- 
ments. Furthermore methodologic differences uch 
as different equilibration times of the tissues with the 
cryomedium before starting the cooling process and 
storage of the samples at -75°C might also have 
contributed to the observed ifferences. 
An increased accumulation of  guanosine 3' ,5' -  
cyclic monophosphate within the vascular smooth- 
muscle cells is the common mechanism by which 
substance P, bradykinin, and nitrovasodilators such 
as sodium nitroprusside licit smooth muscle relax- 
ation. 27 However, whereas sodium nitroprusside is
thought o act directly through activation of  soluble 
guanylate cyclase, 28 both substance P and bradykinin 
first interact with specific receptors on the vascular 
endothelium 29-3~ to trigger nitric oxide formation, 
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which then activates oluble guanylate cyclase in 
smooth muscle cells, leading to increased intracellu- 
lar concentrations of 3',5'-cyclic monophosphate. 32 
In both mesenteric and coronary vascular prepara- 
tions the postthaw endothelium-dependent r laxant 
responses to substance P and bradykinin proved to 
be markedly attenuated compared with those of un- 
frozen control tissues, suggesting again considerable 
cryoinjury of the endothelium. Indeed, morphologic 
examinations revealed an extensive loss of the endo- 
thelial cell lining in both types of arterial rings that 
had been frozen in either medium, thereby excluding 
the possibility that the postthaw functional changes 
were due to a reduction of the number of endothelial 
receptor sites. The correlation between functional 
and morphologic preservation of the endothelial cell 
in arterial preparations is in contrast to findings with 
human saphenous veins, where it seems to be impos- 
sible to predict he endothelial function on the basis 
of microscopic examinations. 33 In both mesenteric and 
coronary arteries postthaw maximal endothelium-inde- 
pendent relaxant responses to sodium nitroprus- 
side were unchanged. However, a slight, although 
not significant, shift to the left of  the sodium 
nitroprusside curve in cryopreserved mesenteric 
arteries was in agreement with the development of  
supersensitivity o nitrovasodilators after the re- 
moval of  basal release of  nitric oxide synthesis in 
deendothelialized vascular tissue. 34 Conversely, 
cryopreserved human coronary arteries proved to 
be significantly tess sensitive to sodium nitroprus- 
side than unfrozen tissues, suggesting that the 
development of  supersensitivity o nitrovasodila- 
tors after deendothelialization is tissue-specific. 
This result is also in line with the observation that 
glyceryl trinitrate relaxes atherosclerotic human 
coronary arteries with reduced potency but unim- 
paired efficacy. 3s Further experiments are required 
to elucidate the mechanism(s) ofcryoinjury and to 
further improve the method for cryopreservation 
of  human arteries. 
In conclusion, these findings support he conten- 
tion that cryopreservation may provide a useful tech- 
nique for the storage of limited supplies of vascular 
tissues not only for scientific research but also for 
graft transplantation. The patency of autogenous 
grafts is definitely superior to that of any artificial 
graft or antigenic allograft. However, cryopreserved 
arteries might be potential alternatives when autoge- 
nous conduits are not available. Cryopreservation 
thus offers the prospect o store different ypes of 
arteries, for example, from multiple organ donors, to 
be readily available for human leucocyte antigen 
matching of donor and recipient before bypass urgery. 
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Fig. 4. Cumulative concentration-response curves on 
rings from human coronary arteries, unfrozen (solid circles) 
and after cryopreservation n KH solution without (empty 
circles) and with 20% fetal calf serum (solid squares). Con- 
tractile responses to PGF2~ expressed in grams (top, for 
each point n = 6) and relaxant responses during active tone 
induced by U46619 (10 nmol/L), for sodium nitroprus- 
side expressed as percentage of tone induced by U46619 in 
addition to passive preload (middle, for each point n = 9), 
and for bradykinin expressed as percentage of maximal 
relaxation induced by 100 Ixmol/L sodium nitroprusside 
(SNP, bottom, for each point n = 6); barsrepresent mean -+ 
SEM. 
Part of these experiments were carried out at Sandoz 
Pharma Ltd. with the gratefully acknowledged technical 
assistance of Mrs. Michele Bretz. 
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